Skip to main content
OpenTrials
Completed

NCT Number: NCT05192031

Implementation of Smoking Cessation Support During Lung Cancer Workup

The aim of the present project is to implement smoking cessation support in hospital-based lung cancer workup. The effect on 1) patients' smoking cessation attempts, motivation, quality of life and psychosocial consequences of lung cancer workup as well as 2) hospitals' number of referrals to municipality-based smoking cessation programmes will be evaluated in a pragmatic, cluster-randomised controlled setup, where participating hospitals will be assigned to the intervention arm (implementation of smoking cessation support) or the control arm (usual practice). Patients' and healthcare professionals' experiences with and barriers towards smoking cessation support will be explored in an interview-based, qualitative study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vejle Hospital

Vejle, 7100, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Referred to lung cancer workup at participating hospital
  • Able to speak and understand Danish

Exclusion criteria

  • Unable to complete electronic questionnaires

Treatment and study plan

Smoking Cessation Support

Behavioral

Training healthcare professionals to deliver smoking cessation support as part of hospital-based lung cancer workup.

Primary outcomes

  1. Proportion of patients making an attempt at smoking cessation during lung cancer workup

    Time frame: 6 weeks after baseline

    Binary outcome (Attempt: yes, no)

Secondary outcomes

  1. Motivation to quit smoking

    Time frame: 6 weeks, 3, 6, and 12 months after baseline

    Numeric rating scale (0-10) with higher score indicating stronger motivation

  2. Proportion of patients who are not smoking at the time of measurement

    Time frame: 6 weeks, 3, 6, and 12 months after baseline

    Binary outcome (Currently smoking: yes, no)

  3. Quality of life as measured by the 36 item Short Form Survey (SF-36)

    Time frame: 6 weeks, 3, 6, and 12 months after baseline

    SF-36, two components: Mental and Physical. Each components scale has a total score range from 5 (worst health) to 80 (best health)

  4. Psychosocial consequences of lung cancer workup

    Time frame: 6 weeks after baseline

    Consequences of Screening - Lung Cancer Questionnaire (adapted to the lung cancer workup setting). Items in Part 1 of the questionnaire focuses on experiences during the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 72 (high level of psychosocial consequences). Items in Part 2 of the questionnaire focuses on experiences after the cancer workup with a total score range from 0 (low level of psychosocial consequences) to 22 (high level of psychosocial consequences).

  5. Hospitals' number of referrals to municipality-based smoking cessation programmes

    Time frame: Change from one year before to one year after intervention

Sponsors and collaborators

Lead sponsor

Vejle Hospital

Other

Collaborators

  • Aalborg University Hospital
  • Aarhus University Hospital
  • Bispebjerg Hospital
  • Hospital of Southern Jutland
  • Naestved Hospital
  • Odense University Hospital
  • University Hospital, Gentofte, Copenhagen
  • Zealand University Hospital

Registry information

Official study title

Implementation of Smoking Cessation Support During Lung Cancer Workup: a Pragmatic, Cluster-randomised Controlled Trial and an Interview-based Study of Patients' and Healthcare Professionals' Experiences

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Jan 14, 2022
Registry last updated
Jun 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.